A Combined Genomewide Linkage Scan of 1,233 Families for Prostate Cancer–Susceptibility Genes Conducted by the International Consortium for Prostate Cancer Genetics
Jianfeng Xu , Latchezar Dimitrov , Bao-Li Chang , Tamara S. Adams
American Journal of Human Genetics 77 ( 2) 219 -229
165
2005
Evaluating Child Malnutrition in Southern Belize Using an Anthropologic Screening Tool
Balise R , Brenner S
2021
Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma
C. Danial , B. Lingala , R. Balise , A.E. Oro
British Journal of Dermatology 169 ( 3) 673 -676
28
2013
Immunocompromised Patients With Prostate Cancer Treated With External Beam Radiation: A Matched Pair Analysis
S.J. Ramey , R. Balise , C. Ritch , S. Punnen
International Journal of Radiation Oncology Biology Physics 93 ( 3)
2
2015
242 Comparison of survival outcomes for African-American and Caucasian men with advanced penile cancer in Florida
C. Ritch , N. Pavan , S. Rai , N. Soodana-Prakash
European Urology Supplements 15 ( 3) e242
2016
335 Nutritional status and major abdominal surgeries: 30-Day postoperative complications
N. Pavan , C. Mir , C. Ritch , S. Rai
European Urology Supplements 15 ( 3) e335
2016
Test-retest reliability of thermal temporal summation using a novel individualized protocol
J. Kong , K. Johnson , R. Balise , S. Mackey
The Journal of Pain 13 ( 4-supp-S) 0
2012
A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors.
P. L. Kunz , T. Kuo , J. M. Zahn , H. L. Kaiser
Journal of Clinical Oncology 28 ( 15_suppl) 4104 -4104
44
2010
Adjuvant chemoradiotherapy with carboplatin and a fluoropyrimidine for resectable gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience
M. A. de Bruin , P. L. Kunz , V. B. Sharma , J. A. Norton
Journal of Clinical Oncology 27 ( 15_suppl) e15674 -e15674
2009
Carboplatin and fluoropyrimidine-based treatment for metastatic gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience
J. M. Ford , P. L. Kunz , M. A. de Bruin , R. R. Balise
Journal of Clinical Oncology 27 ( 15_suppl) e15686 -e15686
2009
Outcome of primary mediastinal large B-cell lymphoma (PMBCL) in the pre- and post-rituximab era: The Stanford University experience.
L. S. Maeda , R. T. Hoppe , R. R. Balise , S. A. Rosenberg
Journal of Clinical Oncology 29
2011
Predictive value for relapse of variation in alpha-fetoprotein (AFP) levels in patients who are in remission from germ cell cancer.
P. Patel , R. R. Balise , S. Srinivas
Journal of Clinical Oncology 28
2010
Predicting Occurrence of Spine Surgery Complications Using "Big Data" Modeling of an Administrative Claims Database
John K. Ratliff , Ray Balise , Anand Veeravagu , Tyler S. Cole
Journal of Bone and Joint Surgery, American Volume 98 ( 10) 824 -834
65
2016
Comparison of Aptt and anti-Xa Activity with Patient Outcomes in a Large Cohort of Hospitalized Patients Treated with Unfractionated Heparin
Jing Jin , Elizabeth A Price , Houng (Marie) Nguyen , Gomathi Krishnan
AMERICAN JOURNAL OF HEMATOLOGY 87 S174 -S174
2012
Abstract# 3036: Telomere length shortening in individuals with sporadic compared with familial breast cancer
Maria Gramatges , Melinda Telli , Ray Balise , James Ford
Cancer Research 69 ( 9_Supplement) 3036 -3036
2009
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
R Senie , I Andrulis , E John , J L Hopper
British Journal of Cancer 91 ( 11) 1911 -1915
226
2004
Focused cardiac ultrasound training: how much is enough?
Christopher B. Chisholm , William R. Dodge , Ray R. Balise , Sarah R. Williams
Journal of Emergency Medicine 44 ( 4) 818 -822
56
2013
ACTANE Consortium: A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics
J Xu , L Dimitrov , BL Chang , TS Adams
Am J Hum Genet 77 ( 2) 219 -229
5
2005
Consortium
J Xu , L Dimitrov , BL Chang , TS Adams
A., A combined genomewide linkage scan of 1 219 -29
Increasing duration of OC use was associated with decreasing risks of ovarian cancer in BRCA1/2 carriers
AS Whittemore , RR Balise , PDP Pharoah , RA DiCioccio
Evidence-based obstetrics and gynecology 7 ( 3) 155 -156
2005